Home › Funds › Rosalind Advisors, Inc. › KURA
Rosalind Advisors, Inc. position in KURA
KURA ONCOLOGY INC · Health Care
Rosalind Advisors, Inc. reported holding 100,000 shares of KURA (KURA ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.44% of its reported portfolio and ranking #28 among its reported holdings. Rosalind Advisors, Inc. has disclosed KURA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rosalind Advisors, Inc.'s KURA position evolved
Rosalind Advisors, Inc. first disclosed a stake in KURA in Q1 2025 at 100,000 shares (US$660K). The position peaked in Q2 2026 at 100,000 shares, worth US$1.1M. Across 7 filings, Rosalind Advisors, Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 100,000 shares valued at US$1.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 100.00K | $660.00K | New |
| Q2 2025 | 100.00K | $577.00K | Hold |
| Q3 2025 | 100.00K | $885.00K | Hold |
| Q4 2025 | 100.00K | $1.04M | Hold |
| Q1 2026 | 100.00K | $813.00K | Hold |
| Q2 2026 | 100.00K | $1.10M | Hold |
| Q3 2026 | 100.00K | $1.07M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KURA and 13F data
KURA (KURA ONCOLOGY INC) is a Health Care company. 26 other funds we track also report a position in KURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$94.1M), BVF INC/IL (US$92.7M), ALETHEA CAPITAL MANAGEMENT, LLC (US$23.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KURA
- MONTANOVA CAPITAL, LLC 8.58M sh · $94.07M · Q2 2026
- BVF INC/IL 8.45M sh · $92.65M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 2.18M sh · $23.30M · Q3 2026
- ARMISTICE CAPITAL, LLC 2.10M sh · $22.45M · Q3 2026
- Prosight Management, LP 1.27M sh · $13.66M · Q3 2026
- NAN FUNG TRINITY (HK) Ltd 1.17M sh · $12.58M · Q3 2026
More on Rosalind Advisors, Inc.
FAQ
How long has Rosalind Advisors, Inc. held KURA?
Rosalind Advisors, Inc. has disclosed KURA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Rosalind Advisors, Inc.'s current position in KURA?
As of Q3 2026, Rosalind Advisors, Inc. holds 100.00K shares of KURA (KURA ONCOLOGY INC), valued at $1.07M, representing 0.44% of its reported portfolio and ranking #28.
Has Rosalind Advisors, Inc. been buying or selling KURA?
In the latest 13F filing (Q3 2026), Rosalind Advisors, Inc. held unchanged its position in KURA. The position peaked in Q2 2026 at 100.00K shares.
Which other funds hold KURA?
Other major institutional holders of KURA include MONTANOVA CAPITAL, LLC, BVF INC/IL, ALETHEA CAPITAL MANAGEMENT, LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.